Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Medecine Sciences : M/S|April 28, 2025
[Role of CD4 T cells in the immune response]Hugo Roux, Olivier LantzPharmaceuticals (Basel, Switzerland)|September 28, 2024
From the "One-Molecule, One-Target, One-Disease" Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) InfectionsHugo Roux, Franck Touret, Pascal Rathelot, et al.Pediatric Blood & Cancer|July 28, 2026
Cup-Like Nuclei Is a Hallmark of DUX4/ERG Acute Lymphoblastic Leukemia and Reveals Cytoplasmic Mitochondria AccumulationChloé Arfeuille, Hugo Roux, Odile Fenneteau, et al.European Journal of Medicinal Chemistry|August 1, 2024
New potent EV-A71 antivirals targeting capsidHugo Roux, Franck Touret, Antonio Coluccia, et al.Cancer Research|August 30, 2022
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast CancerStephane Fattori, Hugo Roux, Emilie Connen, et al.European Journal of Medicinal Chemistry|February 22, 2025
Design and synthesis of novel thioether analogs as promising antiviral agents: In vitro activity against enteroviruses of interestHugo Roux, Franck Touret, Antonio Coluccia, et al.Journal of Experimental & Clinical Cancer Research : CR|February 14, 2025
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinomaIvan Pourmir, Nadine Benhamouda, Thi Tran, et al.Iscience|March 19, 2026
CMV seropositivity associates with poor clinical outcome in triple negative breast cancerRomain-David Seban, Constance Lamy, Luc Cabel, et al.Pageof 1